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Abstract Lateral epicondylitis or tennis elbow is a
painful and functionally limiting entity affecting the
upperextremity and is frequently treated by hand surgeons.
Corticosteroid injection is one of the most common inter-
ventions for lateral epicondylitis or tennis elbow. Here,
a review of the medical literature on this treatment is
presented.
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Introduction
Tennis elbow is a diagnostic term that describes a pattern
of pain and localized tenderness at the lateral epicondyle of
the distal humerus. The anatomic basis of the injury to
the extensor carpi radialis brevis (ECRB) origin appears to
be multifaceted, involving hypovascular zones, eccentric
tendon stresses, and a macroscopic degenerative response.
Although many treatments have been advocated, this
article discusses the treatment of steroid injection for lat-
eral epicondylitis and documents a review of the medical
literature.
Pathology and pathophysiology
Tennis elbow was ﬁrst described in 1883 by Major [1]a sa
condition causing lateral elbow pain in tennis players. Over
the years, this term has become synonymous with all lateral
elbow pain, despite the fact that the condition is most often
work-related and many patients who have this condition do
not play tennis [2].
It has been estimated, however, that 10–50% of people
who regularly play tennis will develop the condition at
some time during their careers [3]. A recent study on
biomechanics demonstrated that the eccentric contractions
of the ECRB muscle during backhand tennis swings,
especially in novice players, are the likely cause of repet-
itive microtrauma that causes tears in the tendon and lateral
epicondylitis [4]. Some others suggested causes of tennis
elbow, or lateral epicondylitis, are trauma to the lateral
region of the elbow, relative hypovascularity of the region
[5], and ﬂuoroquinolone antibiotics [6].
Lateral epicondylitis occurs much more frequently than
medial-sided elbow pain, with ratios reportedly ranging
from 4:1 to 7:1 [7, 8]. In the general population, the inci-
dence is equal among men and women, and in tennis
players, male players are more often affected than female
players [9].
The disorder occurs more often in the dominant
extremity. The average age of the patient who has lateral
epicondylitis is 42 years old, with a bimodal distribution
among the general population. An acute onset of symptoms
occursmoreofteninyoungathletes,andchronic,recalcitrant
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term epicondylitis implied that inﬂammation is present, it is
in fact only present in the very early stages of the disease.
Treatment: corticosteroid injections
Corticosteroid injection has been historically the
most common intervention for lateral epicondylitis. This
intervention must be compared to the efﬁcacy of a ‘‘wait-
and-see’’ policy because the disorder is most often self-
limited.
Smidt et al. [10] reviewed 13 randomized, controlled
trials that evaluated the effects of corticosteroid injections
compared to placebo injection, injection with local anes-
thetic and injection with dexamethasone and triamcino-
lone. Although the evaluated evidence showed superior
short-term effects of corticosteroid injections for lateral
epicondylitis in terms of pain relief and grip strength, no
beneﬁcial effects were found for intermediate- or long-term
follow-up [10].
Among prospective, randomized trials controlled with a
placebo injection, none showed a difference at ﬁnal
evaluation.
Altay et al. [11] compared 60 patients treated with 2 ml
lidocaine to 60 patients treated with 1 ml lidocaine com-
bined with 1 ml triamcinolone, with all injections per-
formed with a peppering technique of 40–50 injections.
Another trial compared disabilities of the arm, shoulder,
and hand score, grip, and pain in 31 patients injected with
lidocaine and dexamethasone and 33 patients injected with
lidocaine only [12]. A third trial randomized 19 subjects to
receive rehabilitation and a sham injection, and 20 to
receive rehabilitation and a corticosteroid injection [13].
There was no signiﬁcant difference between the two groups
on a pain questionnaire, a visual analog pain scale, and a
grip measurement at 4, 8, and 24 weeks (P\0.05). Both
groups improved signiﬁcantly over time, with more than
80% of subjects reporting improvements from baseline to
6 months (P\0.5) [13].
Bisset et al. [14] in Australia and Smidt et al. [15] in the
Netherlands randomized patients with tennis elbow to
physiotherapy, corticosteroid injection, or a ‘‘wait-and-
see’’ approach. In both studies, corticosteroid injection
showed signiﬁcantly better effects at 6 weeks (P\0.01)
but paradoxically high recurrence rates and signiﬁcantly
poorer outcomes at 1 year (P = 0.0001) [15]. In a ran-
domized trial comparing steroid injection to naproxen and
placebo tablets, injections were better at 4 weeks, but over
80% of patients were better by 52 weeks in all groups with
no signiﬁcant differences (P\0.05) [16].
In another double-blinded study comparing different
kinds of steroid injections to lidocaine alone, Price et al.
[17] found that the early response to steroid preparations
was signiﬁcantly better than for lidocaine (P\0.5), but at
24 weeks, the degrees of improvement were similar. Of
interest was the discovery that post-injection worsening of
pain occurred in approximately half of all steroid-treated
patients [17].
Conclusions
Corticosteroid injection is the corner store of care for lat-
eral epicondylitis. The objective of such conservative care
is to relieve pain and reduce inﬂammation, allowing suf-
ﬁcient rehabilitation and return to activities. Although this
treatment has been described as highly successful, there
remains a lack of information concerning the long-term
outcome of steroid treatment. In conclusion, I believe that a
corticosteroid injection runs the risk of delaying resolution
of symptoms in the long run.
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